Delivery Order SPE2DB24D3013-SPE2DB25FFFNB

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,248.08 firm fixed-price contract is for the delivery of Vraylar 1.5 mg capsules. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,380.90, is for the delivery of Vraylar 4.5 mg capsules. It is a Firm Fixed Price delivery order contract with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,212.91 firm fixed-price contract is for the delivery of Vraylar 4.5 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $6,717.19 firm fixed-price order is for the supply of Vraylar 4.5 mg capsules, a prescription medication. The contract has an ultimate completion date of June 26, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, serving as the primary vehicle for the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,440.12 firm fixed-price contract is for the delivery of Vraylar 1.5 mg capsules, with a completion date of November 18, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order, valued at $4,635.48, is for the supply of Vraylar 6 mg capsules. This order falls under an Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Vraylar 1.5 mg capsules. The contract has a ceiling value of $26,992.52 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type without any set-aside designation. AmerisourceBergen, through its Corporate Office division, will provide these prescription medications to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,918.42 delivery order is for the supply of 4565713714 - Vraylar 1.5 mg capsules, a medication used to treat certain mental health conditions. The delivery order has a firm fixed price and an ultimate completion date of September 9, 2024. Amerisourcebergen is an experienced federal contractor, holding multiple Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical distribution company. The contract, valued at $3,099.35, is for the delivery of Vraylar 3 mg capsules. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 from DLA Troop Support Medical, which serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Vraylar 6 mg capsules. The contract has a ceiling value of $3,178.25 and an ultimate completion date of August 23, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, leverages its extensive supply chain to provide a wide range of prescription medications and medical supplies to...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFNB
    Delivery Order

This is a $9,834.12 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the supply of Vraylar 4.5 mg capsules for the government. AmerisourceBergen is a major pharmaceutical distributor in the U.S. and holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical to provide a comprehensive range of medical commodities. This delivery order does not have a set-aside designation and is scheduled for completion on October 8, 2024.

Generated 1/6/25, 12:35 PM